Breaking News Instant updates and real-time market news.

PTN

Palatin

$0.33

-0.007 (-2.07%)

, AMAG

Amag Pharmaceuticals

07:37
03/20/17
03/20
07:37
03/20/17
07:37

Palatin: USPTO isses Notice of Allowance for patent serial number 14/704,223

Palatin Technologies (PTN) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application Serial Number 14/704,223. The allowed claims are for methods of treating female sexual dysfunction and hypoactive sexual desire disorder with bremelanotide, an investigational product designed for on-demand treatment of HSDD in premenopausal women. Once issued, the patent will have a term to November 2033. Stephen Wills, COO and CFO of Palatin, commented, "We are pleased to have received a notice of allowance from the USPTO, which signifies that a patent can be granted from an application. We believe that this patent, with a term out to 2033, further strengthens the intellectual property portfolio for the bremelanotide development program." Palatin previously announced positive Phase 3 results with bremelanotide for treating HSDD in premenopausal women. Palatin has entered into an agreement with AMAG Pharmaceuticals (AMAG) granting AMAG exclusive North American rights to develop and commercialize bremelanotide.

PTN

Palatin

$0.33

-0.007 (-2.07%)

AMAG

Amag Pharmaceuticals

PTN Palatin
$0.33

-0.007 (-2.07%)

11/02/16
ROTH
11/02/16
NO CHANGE
Target $7
ROTH
Buy
Palatin price target raised to $7 from $4 at Roth Capital
01/10/17
LEER
01/10/17
DOWNGRADE
Target $25
LEER
Market Perform
AMAG Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
Leerink analyst Joseph Schwartz downgraded AMAG Pharmaceuticals (AMAG) to Market Perform from Outperform after the company provided a "disappointing update" related to the Makena auto-injector program. Furthermore, the analyst notes that the licensing agreement with Palatin (PTN) for its hypoactive sexual desire disorder drug Rekynda could drive incremental value but will require "sizable upfront investment" and have to clear regulatory and commercialization hurdles before that takes place. Nonetheless, Schwartz notes that AMAG's preliminary Q4 results and FY17 financial estimates were in-line with his bullish outlook for 2016-2017. He also lowered his price target on AMAG's shares to $25 from $39.
AMAG Amag Pharmaceuticals

01/10/17
NEED
01/10/17
DOWNGRADE
NEED
Hold
AMAG Pharmaceuticals downgraded to Hold from Buy at Needham
01/31/17
JPMS
01/31/17
NO CHANGE
Target $24
JPMS
Neutral
AMAG Pharmaceuticals price target lowered to $24 from $33 at JPMorgan
JPMorgan analyst Jessica Fye lowered her price target for AMAG Pharmaceuticals to $24 following updates at her firm's healthcare conference, including the shift in Makena strategy, Rekynda in-licensing and 2017 guidance. The analyst keeps a Neutral rating on the shares.
02/03/17
COWN
02/03/17
DOWNGRADE
Target $25
COWN
Market Perform
AMAG Pharmaceuticals downgraded to Market Perform from Outperform at Cowen
Cowen analyst Ken Cacciatore downgraded AMAG Pharmaceuticals to Market Perform from Outperform on the belief that the franchise extension strategy for Makena will unfortunately fail. The analyst also questions the business decisions made after acquiring Makena, such as buying CBR, which could prove to be value destroying. Cacciatore lowered his price target to $25 from $35 on AMAG Pharmaceuticals shares.
03/15/17
RAJA
03/15/17
NO CHANGE
RAJA
Raymond James says new study highlights risks for AMAG
Raymond James analyst Christopher Raymond says a new study in the American Journal of Obstetrics and Gynecology questions the therapeutic utility of hydroxyprogesterone caproate for preterm birth also highlights a potential safety signal. Hydroxyprogesterone caproate is the active ingredient in AMAG Pharmaceuticals' Makena. The analyst has an Underpeform rating on the shares.

TODAY'S FREE FLY STORIES

WLH

William Lyon Homes

$29.55

-0.33 (-1.10%)

11:51
11/24/17
11/24
11:51
11/24/17
11:51
Conference/Events
William Lyon Homes management to meet with Wedbush »

Meeting with CFO Severn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLDR

Builders FirstSource

$19.52

0.07 (0.36%)

11:49
11/24/17
11/24
11:49
11/24/17
11:49
Conference/Events
Builders FirstSource management to meet with Wedbush »

Meeting with CFO Jackson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUN

Cedar Fair

$67.06

0.51 (0.77%)

11:47
11/24/17
11/24
11:47
11/24/17
11:47
Conference/Events
Cedar Fair management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

HOG

Harley-Davidson

$47.26

-0.42 (-0.88%)

, PII

Polaris Industries

$123.17

-0.41 (-0.33%)

11:43
11/24/17
11/24
11:43
11/24/17
11:43
Conference/Events
Wedbush leisure analyst holds an analyst/industry luncheon meeting »

Leisure Analyst Haridman…

HOG

Harley-Davidson

$47.26

-0.42 (-0.88%)

PII

Polaris Industries

$123.17

-0.41 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$115.91

0.83 (0.72%)

11:40
11/24/17
11/24
11:40
11/24/17
11:40
Options
One week call buyers in Pepsico »

One week call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$19.10

-0.07 (-0.37%)

11:36
11/24/17
11/24
11:36
11/24/17
11:36
Periodicals
Nissan plans to unveil new gasoline-fueled engine next week, Reuters says »

Nissan plans to keep…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

ECYT

Endocyte

$4.82

0.07 (1.47%)

, PGNX

Progenics

$5.59

0.06 (1.09%)

11:35
11/24/17
11/24
11:35
11/24/17
11:35
Conference/Events
Wedbush biotech analyst holds an analyst/industry conference call »

Biotech Analyst…

ECYT

Endocyte

$4.82

0.07 (1.47%)

PGNX

Progenics

$5.59

0.06 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$15.46

-0.16 (-1.02%)

11:35
11/24/17
11/24
11:35
11/24/17
11:35
Options
CB&I put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AAPL

Apple

$174.96

1.82 (1.05%)

11:20
11/24/17
11/24
11:20
11/24/17
11:20
Options
Active trading in Apple expiring options »

Active trading in Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$102.78

0.04 (0.04%)

, VIAB

Viacom

$26.68

-0.58 (-2.13%)

11:19
11/24/17
11/24
11:19
11/24/17
11:19
Hot Stocks
Box Office Battle: 'Coco' looking to take top spot from 'Justice League' »

"Coco," the…

DIS

Disney

$102.78

0.04 (0.04%)

VIAB

Viacom

$26.68

-0.58 (-2.13%)

LGF.B

Lionsgate

$31.68

0.355 (1.13%)

SNE

Sony

$47.92

0.7 (1.48%)

LGF.A

Lionsgate

$33.31

0.33 (1.00%)

FOXA

21st Century Fox

$30.61

-0.27 (-0.87%)

FOX

21st Century Fox

$29.94

-0.16 (-0.53%)

CMCSK

Comcast

CMCSA

Comcast

$36.41

-0.01 (-0.03%)

TWX

Time Warner

$89.91

-0.1 (-0.11%)

VIA

Viacom

$32.90

-0.45 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$NSD

NASDAQ Market Internals

11:17
11/24/17
11/24
11:17
11/24/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
11/24/17
11/24
11:16
11/24/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNC

GNC Holdings

$5.65

0.2 (3.67%)

11:15
11/24/17
11/24
11:15
11/24/17
11:15
Options
GNC Holdings put volume heavy and directionally bearish »

Bearish flow noted in GNC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$61.05

0.6 (0.99%)

11:05
11/24/17
11/24
11:05
11/24/17
11:05
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$21.56

0.93 (4.51%)

10:50
11/24/17
11/24
10:50
11/24/17
10:50
Options
Macy's calls outpace puts 2:1 as shares see strength »

Macy's calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

GM

General Motors

$44.37

0.075 (0.17%)

10:40
11/24/17
11/24
10:40
11/24/17
10:40
Options
10K GM Dec 44 calls sold at $1.20 »

10K GM Dec 44 calls sold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 09

    Jan

  • 16

    Jan

M

Macy's

$21.57

0.9366 (4.54%)

10:38
11/24/17
11/24
10:38
11/24/17
10:38
Technical Analysis
Technical View: Macy's ticks top of downtrend resistance line »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

MSON

Misonix

$10.58

0.025 (0.24%)

10:36
11/24/17
11/24
10:36
11/24/17
10:36
Hot Stocks
Breaking Hot Stocks news story on Misonix »

South Africa Alpha…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$54.89

-1.01 (-1.81%)

, NTDOY

Nintendo

$50.55

0.72 (1.44%)

10:35
11/24/17
11/24
10:35
11/24/17
10:35
Periodicals
Tencent denies rumor of Nintendo gaming JV in China, Marbridge Daily says »

Tencent (TCEHY) has…

TCEHY

Tencent

$54.89

-1.01 (-1.81%)

NTDOY

Nintendo

$50.55

0.72 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,175.50

19.08 (1.65%)

10:34
11/24/17
11/24
10:34
11/24/17
10:34
Periodicals
Amazon workers in Germany, Italy strike on Black Friday, TechCrunch reports »

Workers at Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

UEPS

Net 1 UEPS

$12.28

2.16 (21.34%)

10:30
11/24/17
11/24
10:30
11/24/17
10:30
Options
Notable new position opened in Net 1 Ueps Tech as shares stumble »

Notable new position…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FORR

Forrester

$46.55

-0.15 (-0.32%)

10:25
11/24/17
11/24
10:25
11/24/17
10:25
Conference/Events
Forrester management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 29

    Nov

  • 05

    Dec

MRO

Marathon Oil

$15.04

0.161 (1.08%)

10:25
11/24/17
11/24
10:25
11/24/17
10:25
Options
Marathon Oil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

GRC

Gorman-Rupp

$32.18

-0.29 (-0.89%)

10:24
11/24/17
11/24
10:24
11/24/17
10:24
Conference/Events
Gorman-Rupp management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

SKYW

SkyWest

$50.40

-1 (-1.95%)

10:22
11/24/17
11/24
10:22
11/24/17
10:22
Conference/Events
SkyWest management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.